Bicycle Therapeutics (NASDAQ:BCYC) Given New $15.00 Price Target at Barclays
Bicycle Therapeutics (NASDAQ:BCYC – Free Report) had its price target cut by Barclays from $40.00 to $15.00 in a research report sent to investors on Thursday,Benzinga reports. They currently have an overweight rating on the stock. A number of other research analysts also recently commented on BCYC. HC Wainwright reiterated a “buy” rating and issued […]
Bicycle Therapeutics (NASDAQ:BCYC – Free Report) had its price target cut by Barclays from $40.00 to $15.00 in a research report sent to investors on Thursday,Benzinga reports. They currently have an overweight rating on the stock. A number of other research analysts also recently commented on BCYC. HC Wainwright reiterated a “buy” rating and issued […]
